4-Antibody Announces a Long-Term Collaboration With Boehringer Ingelheim for Therapeutic Antibodies

BASEL, Switzerland, March 16, 2010 – 4-Antibody AG today announces a major long-term collaboration with
Boehringer Ingelheim to discover and to develop fully human therapeutic
antibodies for a number of targets in various disease indications. 4-Antibody
will use its proprietary and unencumbered Hu-PAC(R) and Retrocyte Display(R)
technologies for the discovery and development of fully human antibodies
against novel targets [...]

PERSEUS Trial Results Demonstrate Positive Safety and Efficacy Outcomes for Boston Scientific’s Novel Platinum Chromium TAXUS(R) Element(TM) Stent System

NATICK, Massachusetts and ATLANTA, Georgia, March 16, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced
12-month results from its PERSEUS clinical program that demonstrated positive
safety and efficacy outcomes in workhorse lesions for the platinum chromium
TAXUS(R) Element(TM) Paclitaxel-Eluting Stent System compared to the TAXUS(R)
Express2(TM) Paclitaxel-Eluting Stent System. The results also reported a
similar safety profile and [...]

‘Listen To Your Brain,’ World’s First Neuromarketing Music Video, Launches From NeuroFocus

Four-Minute Production Praised As 'Funnier Than Any Film At South By Southwest'

BERKELEY, California, March 16, 2010 – The tweets flew fast and furious at the famous South By Southwest Music,
Film, & Interactive Festival in Austin, Texas when "Listen To Your Brain"
(www.youtube.com/user/neurofocus#p/a/u/0/RUzo7fhRpFY) began playing on
the big screen.
Created by NeuroFocus, the world's [...]

Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals

DUBLIN, March 16, 2010 – Shire plc (LSE: SHP, NASDAQ; SHPGY), announces that it has received a
Paragraph IV Notice Letter from Teva Pharmaceuticals USA, Inc. ("Teva")
advising of the filing of an Abbreviated New Drug Application ("ANDA") for a
generic version of Shire's 1 mg, 2mg, 3 mg, and 4mg guanfacine hydrochloride
extended release tablets, INTUNIV(TM).

[...]